Julie McHugh
Fortune : 4 M $ au 31/07/2026
Fortune : 4 M $ au 31/07/2026
Julie Harris McHugh is currently Chairman at Ironwood Pharmaceuticals, Inc. since 2019.
Director at Lantheus Medical Imaging, Inc. since 2017.
Director at Xellia Pharmaceuticals ApS since 2013.
Director at The Nathaniel Adamczyk Foundation.
Lead Independent Director at Lantheus Holdings, Inc. since 2024.
Director at New Xellia Group A since 2013.
Advisor at Healthcare Royalty Management LLC since 2016.
Former Chief Executive Officer at Nora Therapeutics, Inc. in 2009.
Group Chairman-Worldwide Virology Business Unit at Johnson & Johnson from 2006 to 2008.
Chairman at Life Sciences Pennsylvania.
Director at Shire ViroPharma, Inc. from 2012 to 2014.
Director at Penwest Pharmaceuticals Co. Independent Director at Aerie Pharmaceuticals, Inc. from 2015 to 2022.
Director at Biotechnology Innovation Organization.
Director at New England Healthcare Institute.
Director at Xellia Pharmaceuticals AS.
Independent Director at Trevena, Inc. from 2014 to 2021.
Director at Zalicus, Inc. Director at Bucks County Biotechnology Center, Inc. Independent Director at EPIRUS Biopharmaceuticals, Inc. from 2014 to 2016.
Director at Evelo Biosciences, Inc. from 2021 to 2023.
Director at Viropharma, Inc. from 2012 to 2014.
President at Centocor, Inc. from 2004 to 2006.
Chief Operating Officer at Endo Health Solutions, Inc. from 2010 to 2013.
Education includes undergraduate degree from The Pennsylvania State University and MBA from St. Joseph's University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LANTHEUS HOLDINGS INC 0,05 % | 14/05/2026 | 30 099 ( 0,05 % ) | 3 M $ | 31/07/2026 |
| 16/06/2026 | 250 749 ( 0,15 % ) | 1 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Président | 01/04/2019 |
| LANTHEUS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/01/2017 |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services | Directeur/Membre du Conseil | 01/09/2013 |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Consultant / Advisor | 01/01/2016 |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Directeur/Membre du Conseil | 01/02/2017 |
New Xellia Group A/S
New Xellia Group A/S Financial ConglomeratesFinance Operates as an investment holding company | Directeur/Membre du Conseil | 01/09/2013 |
The Nathaniel Adamczyk Foundation | Directeur/Membre du Conseil | 07/10/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/07/2023 |
| AERIE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 21/11/2022 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 26 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Health Technology |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Commercial Services |
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs | Health Technology |
Trevena, Inc.
Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages | Health Technology |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Provides anti-infective treatments and other critical care therapies services | Health Services |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
The Nathaniel Adamczyk Foundation | |
Lantheus Holdings, Inc.
Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
Pennsylvania Biotechnology Center of Bucks County
Pennsylvania Biotechnology Center of Bucks County Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit research organization | Commercial Services |
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
New Xellia Group A/S
New Xellia Group A/S Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Evelo Biosciences, Inc.
Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Viropharma, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national